Phase II trial of trabectedin (T) in heavily pretreated recurrent ovarian cancer (ROC) patients.
D. Lorusso
No relevant relationships to disclose
P. Malaguti
No relevant relationships to disclose
V. Masciullo
No relevant relationships to disclose
S. Mainenti
No relevant relationships to disclose
A. di Legge
No relevant relationships to disclose
M. Ludovisi
No relevant relationships to disclose
A. Pesce
No relevant relationships to disclose
F. Mascilini
No relevant relationships to disclose
E. Fusco
No relevant relationships to disclose
G. Scambia
No relevant relationships to disclose